Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma

BACKGROUND: The high mutation rate of TP53 in hepatocellular carcinoma (HCC) makes it an attractive potential therapeutic target. However, the mechanism by which TP53 mutation affects the prognosis of HCC is not fully understood. MATERIAL AND APPROACH: This study downloaded a gene expression profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Junyu, Wu, Liqun, Zang, Yunjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222811/
https://www.ncbi.nlm.nih.gov/pubmed/34178618
http://dx.doi.org/10.3389/fonc.2021.618976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222811/
https://www.ncbi.nlm.nih.gov/pubmed/34178618
http://dx.doi.org/10.3389/fonc.2021.618976

Ejemplares similares